Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Eradication of hepatitis C virus subgenomic replicon by interferon results in aberrant retinol-related protein expression.

Koike K, Takaki A, Kato N, Ouchida M, Kanzaki H, Yasunaka T, Shiraha H, Miyake Y, Yamamoto K.

Acta Med Okayama. 2012;66(6):461-8.

2.

Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon.

Fang C, Yi Z, Liu F, Lan S, Wang J, Lu H, Yang P, Yuan Z.

Proteomics. 2006 Jan;6(2):519-27.

PMID:
16317778
3.

cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.

Abe K, Ikeda M, Dansako H, Naka K, Shimotohno K, Kato N.

Virus Res. 2005 Jan;107(1):73-81.

PMID:
15567036
4.

Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro.

Kato N, Sugiyama K, Namba K, Dansako H, Nakamura T, Takami M, Naka K, Nozaki A, Shimotohno K.

Biochem Biophys Res Commun. 2003 Jul 4;306(3):756-66.

PMID:
12810084
5.

Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum.

Benedicto I, Molina-Jiménez F, Barreiro O, Maldonado-Rodríguez A, Prieto J, Moreno-Otero R, Aldabe R, López-Cabrera M, Majano PL.

Hepatology. 2008 Oct;48(4):1044-53. doi: 10.1002/hep.22465.

PMID:
18802961
6.

Bile acids promote the expression of hepatitis C virus in replicon-harboring cells.

Chang KO, George DW.

J Virol. 2007 Sep;81(18):9633-40. Epub 2007 Jul 3.

7.

Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines.

Ye F, Xin Z, Han W, Fan J, Yin B, Wu S, Yang W, Yuan J, Qiang B, Sun W, Peng X.

PLoS One. 2015 Nov 6;10(11):e0142082. doi: 10.1371/journal.pone.0142082. eCollection 2015.

8.

Cloning and expression of retinoic acid-induced gene-I and its effect on hepatitis C virus replication.

Shen Y, Qian Y, Shen L, Wu Z, Xu C, Tong X.

Lab Med. 2014 Spring;45(2):103-10.

PMID:
24868989
9.

Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients.

Jacobs JM, Diamond DL, Chan EY, Gritsenko MA, Qian W, Stastna M, Baas T, Camp DG 2nd, Carithers RL Jr, Smith RD, Katze MG.

J Virol. 2005 Jun;79(12):7558-69.

10.

Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.

Zhang T, Lin RT, Li Y, Douglas SD, Maxcey C, Ho C, Lai JP, Wang YJ, Wan Q, Ho WZ.

Hepatology. 2005 Oct;42(4):819-27.

PMID:
16175599
11.

Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells.

Fillebeen C, Muckenthaler M, Andriopoulos B, Bisaillon M, Mounir Z, Hentze MW, Koromilas AE, Pantopoulos K.

J Hepatol. 2007 Jul;47(1):12-22. Epub 2007 Mar 2.

PMID:
17399844
12.

Zebrafish as a potential model organism for drug test against hepatitis C virus.

Ding CB, Zhang JP, Zhao Y, Peng ZG, Song DQ, Jiang JD.

PLoS One. 2011;6(8):e22921. doi: 10.1371/journal.pone.0022921. Epub 2011 Aug 8.

13.

Morphine withdrawal enhances hepatitis C virus replicon expression.

Wang CQ, Li Y, Douglas SD, Wang X, Metzger DS, Zhang T, Ho WZ.

Am J Pathol. 2005 Nov;167(5):1333-40.

14.

Mutual antagonism between circadian protein period 2 and hepatitis C virus replication in hepatocytes.

Benegiamo G, Mazzoccoli G, Cappello F, Rappa F, Scibetta N, Oben J, Greco A, Williams R, Andriulli A, Vinciguerra M, Pazienza V.

PLoS One. 2013 Apr 8;8(4):e60527. doi: 10.1371/journal.pone.0060527. Print 2013.

15.

SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.

Poat B, Hazari S, Chandra PK, Gunduz F, Balart LA, Alvarez X, Dash S.

PLoS One. 2010 Sep 30;5(9). pii: e13117. doi: 10.1371/journal.pone.0013117.

16.

Affinity capture and identification of host cell factors associated with hepatitis C virus (+) strand subgenomic RNA.

Upadhyay A, Dixit U, Manvar D, Chaturvedi N, Pandey VN.

Mol Cell Proteomics. 2013 Jun;12(6):1539-52. doi: 10.1074/mcp.M112.017020. Epub 2013 Feb 21.

17.

Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).

Miyamoto M, Kato T, Date T, Mizokami M, Wakita T.

Intervirology. 2006;49(1-2):37-43.

PMID:
16166787
18.

Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.

Chang JH, Kato N, Muroyama R, Taniguchi H, Guleng B, Dharel N, Shao RX, Tateishi K, Jazag A, Kawabe T, Omata M.

Liver Int. 2010 Feb;30(2):311-8. doi: 10.1111/j.1478-3231.2009.02144.x. Epub 2009 Oct 16.

PMID:
19840259
19.

Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.

Sun LJ, Yu JW, Wan L, Zhang XY, Shi YG, Chen MY.

Int J Infect Dis. 2014 Jun;23:75-81. doi: 10.1016/j.ijid.2013.12.017. Epub 2014 Apr 2.

20.

Replication of a hepatitis C virus replicon clone in mouse cells.

Uprichard SL, Chung J, Chisari FV, Wakita T.

Virol J. 2006 Oct 28;3:89.

Supplemental Content

Support Center